These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
87 related articles for article (PubMed ID: 15193351)
1. Erythropoietin: a new tool for muscle disorders? Scoppetta C; Grassi F Med Hypotheses; 2004; 63(1):73-5. PubMed ID: 15193351 [TBL] [Abstract][Full Text] [Related]
2. Erythropoietin improves functional and histological recovery of traumatized skeletal muscle tissue. Rotter R; Menshykova M; Winkler T; Matziolis G; Stratos I; Schoen M; Bittorf T; Mittlmeier T; Vollmar B J Orthop Res; 2008 Dec; 26(12):1618-26. PubMed ID: 18634017 [TBL] [Abstract][Full Text] [Related]
3. The erythropoietin receptor and its expression in tumor cells and other tissues. Farrell F; Lee A Oncologist; 2004; 9 Suppl 5():18-30. PubMed ID: 15591419 [TBL] [Abstract][Full Text] [Related]
4. Erythropoietin receptor in human skeletal muscle and the effects of acute and long-term injections with recombinant human erythropoietin on the skeletal muscle. Lundby C; Hellsten Y; Jensen MB; Munch AS; Pilegaard H J Appl Physiol (1985); 2008 Apr; 104(4):1154-60. PubMed ID: 18218911 [TBL] [Abstract][Full Text] [Related]
5. The biochemistry of drugs and doping methods used to enhance aerobic sport performance. Cooper CE Essays Biochem; 2008; 44():63-83. PubMed ID: 18384283 [TBL] [Abstract][Full Text] [Related]
6. [Erythropoietin - state of science]. Schöffel N; Börger JA; Quarcoo D; Scutaru C; Groneberg DA Sportverletz Sportschaden; 2008 Dec; 22(4):201-6. PubMed ID: 19085770 [TBL] [Abstract][Full Text] [Related]
7. Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant erythropoietin misuse. Abellan R; Ventura R; Pichini S; Palmi I; Bellver M; Olive R; Pacifici R; Pascual JA; Zuccaro P; Segura J Int J Sports Med; 2007 Jan; 28(1):9-15. PubMed ID: 16804802 [TBL] [Abstract][Full Text] [Related]
8. Erythropoietin promotes endothelial progenitor cell proliferative and adhesive properties in a PI 3-kinase-dependent manner. George J; Goldstein E; Abashidze A; Wexler D; Hamed S; Shmilovich H; Deutsch V; Miller H; Keren G; Roth A Cardiovasc Res; 2005 Nov; 68(2):299-306. PubMed ID: 16048724 [TBL] [Abstract][Full Text] [Related]
9. Immune responses against tetracycline-dependent transactivators affect long-term expression of mouse erythropoietin delivered by a helper-dependent adenoviral vector. Lena AM; Giannetti P; Sporeno E; Ciliberto G; Savino R J Gene Med; 2005 Aug; 7(8):1086-96. PubMed ID: 15772935 [TBL] [Abstract][Full Text] [Related]
10. Non-erythroid activities of erythropoietin: Functional effects on murine dendritic cells. Lifshitz L; Prutchi-Sagiv S; Avneon M; Gassmann M; Mittelman M; Neumann D Mol Immunol; 2009 Feb; 46(4):713-21. PubMed ID: 19027957 [TBL] [Abstract][Full Text] [Related]
11. EPO use by Brazilian athletes since 2000. Almeida CB; Rodrigues DN; Barros EC Subst Use Misuse; 2014 Jul; 49(9):1126-31. PubMed ID: 24832719 [TBL] [Abstract][Full Text] [Related]
12. Erythropoietin reduces the degree of arthritis caused by type II collagen in the mouse. Cuzzocrea S; Mazzon E; di Paola R; Genovese T; Patel NS; Britti D; de Majo M; Caputi AP; Thiemermann C Arthritis Rheum; 2005 Mar; 52(3):940-50. PubMed ID: 15751086 [TBL] [Abstract][Full Text] [Related]
13. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis. Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691 [TBL] [Abstract][Full Text] [Related]
14. Testing for recombinant erythropoietin. Delanghe JR; Bollen M; Beullens M Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255 [TBL] [Abstract][Full Text] [Related]
15. Erythropoietin, a hypoxia-regulated factor, elicits a pro-angiogenic program in human mesenchymal stem cells. Zwezdaryk KJ; Coffelt SB; Figueroa YG; Liu J; Phinney DG; LaMarca HL; Florez L; Morris CB; Hoyle GW; Scandurro AB Exp Hematol; 2007 Apr; 35(4):640-52. PubMed ID: 17379074 [TBL] [Abstract][Full Text] [Related]
16. Monitoring gene therapy by external imaging of mRNA: pilot study on murine erythropoietin. Segura J; Fillat C; Andreu D; Llop J; Millan O; de la Torre BG; Nikolovski Z; Gomez V; Andreu N; Pinyot A; Castelo R; Gispert JD; Pascual JA Ther Drug Monit; 2007 Oct; 29(5):612-8. PubMed ID: 17898652 [TBL] [Abstract][Full Text] [Related]
17. Synergy between erythropoietin and stem cell factor during erythropoiesis can be quantitatively described without co-signaling effects. Wang W; Horner DN; Chen WL; Zandstra PW; Audet J Biotechnol Bioeng; 2008 Apr; 99(5):1261-72. PubMed ID: 17969148 [TBL] [Abstract][Full Text] [Related]
18. Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Jelkmann W; Wagner K Ann Hematol; 2004 Nov; 83(11):673-86. PubMed ID: 15322761 [TBL] [Abstract][Full Text] [Related]
19. Erythropoietin protects cardiomyocytes from apoptosis via up-regulation of endothelial nitric oxide synthase. Burger D; Lei M; Geoghegan-Morphet N; Lu X; Xenocostas A; Feng Q Cardiovasc Res; 2006 Oct; 72(1):51-9. PubMed ID: 16904088 [TBL] [Abstract][Full Text] [Related]
20. ERK-mediated production of neurotrophic factors by astrocytes promotes neuronal stem cell differentiation by erythropoietin. Park MH; Lee SM; Lee JW; Son DJ; Moon DC; Yoon DY; Hong JT Biochem Biophys Res Commun; 2006 Jan; 339(4):1021-8. PubMed ID: 16337149 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]